Original ArticlesClinical and radiographic results of cementless AML total hip arthroplasty in young patients*,**
Section snippets
Materials and methods
A retrospective study was undertaken of the clinical and radiographic results of 61 cementless THAs (60 patients) using a two thirds porous-surfaced femoral component with 32-mm cobalt-chrome articulation with high-density polyethylene and porous-surfaced acetabular component (AML DePuy, Warsaw, IN) performed between 1984 and 1989. Nine hips (8 patients) were lost to follow-up and excluded from the study. Of 52 patients (52 hips), there were 34 men and 18 women with an average age of 48.3 years
Results
The results at last follow-up were 35 excellent (67%), 11 good (21%), 2 fair (4%), and 4 poor (8%) (Fig. 1).Excluding the converted hemiarthroplasty group, the results at last follow-up are similar: 31 excellent (67%), 10 good (22%), 2 fair (4%), and 3 poor (7%). The mean postoperative scores for pain, function, and mobility were 5.4, 5.6, and 5.7. Forty-two patients (81%) developed mild to moderate pain along the anterior thigh 3
Discussion
This study presents a group of young patients, most with the diagnosis of avascular necrosis of the hip, followed for a mean 10.5 years after AML cementless THA. Forty-six patients (88%) had good or excellent results. Two patients (4%) had a fair rating; both of these patients had undergone conversion from cementless hemiarthroplasties. Of the 6 patients who had conversion surgeries, only 1 had an excellent result. Although the results from conversions are worse, the overall results are
References (27)
- et al.
The rationale for cemented total hip arthroplasty
Orthop Clin North Am
(1993) - et al.
Five year clinical and radiographic follow-up of the uncemented long-term stable fixation total hip arthroplasty
J Arthroplasty
(1998) - et al.
Loosening of total hip components: cause and prevention
Total hip arthroplasty: clinical perspectives
Clin Orthop
(1992)- et al.
Total hip replacement in patients younger than thirty years old: a five-year follow-up study
J Bone Joint Surg Am
(1981) - et al.
Total hip replacement failures: A histological evaluation
J Bone Joint Surg Am
(1973) - et al.
Total hip arthroplasties in patients less than forty-five years old
J Bone Joint Surg Am
(1983) - et al.
Eight year results of Charnley arthroplasties of the hip with special reference to the behavior of cement
Clin Orthop
(1978) Ten-year follow-up study of total hip replacement
J Bone Joint Surg Am
(1982)- et al.
Reaction of bone to methacrylate after hip arthroplasty: a long-term gross, light microscopic, and scanning electron microscopic study
J Bone Joint Surg Am
(1974)
Biologic fixation of a modified Moore prosthesis: evaluation of early clinical results
The removal of porous-coated femoral hip stems
Clin Orthop
The porous-coated anatomic total hip prosthesis, inserted without cement: Results after five to seven years in a prospective study
J Bone Joint Surg Am
Cited by (42)
Wagner Cone Midterm Survivorship and Outcomes
2020, Journal of ArthroplastyCitation Excerpt :The most commonly used femoral stems in primary THA today are metaphyseal engaging flat-wedge tapers, and revision for aseptic femoral loosening has been reported as less than 1% for the Taperloc (Zimmer-Biomet, Warsaw, IN) [17–19], Trilock (DePuy, Warsaw, IN) [20,21], and Accolade (Stryker, Mahwah, NJ) [22] in midterm and long-term follow-up studies. Similarly, there has been a less than 1% reported rate of revision for aseptic loosening for the anatomic medullary locking (DePuy, Warsaw, IN) [23–25], an extensively porous-coated cylindrical stem. In our series of midterm follow-up of the Wagner cone femoral prosthesis, the 0% rate of revision for aseptic loosening and 0% rate of revision for subsidence compare favorably to previously reported results for commonly used femoral stems.
Cementless Femoral Components in Young Patients. Review and Meta-Analysis of Total Hip Arthroplasty and Hip Resurfacing
2009, Journal of ArthroplastyCitation Excerpt :Both acetabular and femoral components were cemented. The results of modern cementless THA in young patients are quite encouraging [8-28,47]. A meta-analysis of cementless femoral component survivorship in young patients (9 studies) in our study was 95% at 12 years.
Total Hip Arthroplasty with a Collarless, Tapered, Fiber Metal Proximally Coated Femoral Stem. Minimum 5-Year Follow-Up
2009, Journal of ArthroplastyCitation Excerpt :The FMT prosthesis, like other proximally coated, tapered stems, was designed to reduce proximal stress shielding. A considerable amount of stress shielding is frequently seen around extensively coated stems [22,23]. Although dual-energy x-ray absorptiometry was not performed in this study, radiographic findings suggestive of stress shielding (calcar rounding and gross proximal femur radiographic osteopenia) were only seen in 21% of hips.
Midterm Results of "Thrust Plate" Prosthesis
2007, Journal of ArthroplastyCitation Excerpt :Kronick et al [24] reported a femoral revision rate of 1.1% after following up on 174 cementless stemmed endoprostheses in patients younger than 50 years for an average period of 8.3 years. Nercessian et al [25] reported a rate of 5.8% in 52 AML stem cases after an average period of 10.5 years, whereas Kim et al [15] did not find any revision of femoral components due to loosening in 118 cementless stemmed prostheses implanted in patients with an average age of 46.8 years after an average follow-up period of 9.8 years. Moreover, in the current study there was no significant difference in the survival rates of TPPs in patients up to 50 years of age and those who were older, which ruled out young age as an influencing factor on failures.
Uncemented grit-blasted straight tapered titanium stems in patients younger than fifty-five years of age: Fifteen to twenty-year results
2009, Journal of Bone and Joint SurgeryInfluence of trabecular bone quality and implantation direction on press-fit mechanics
2017, Journal of Orthopaedic Research
- *
No benefits or funds were received in support of this study.
- **
Reprint requests: Ohannes A. Nercessian, MD, Department of Orthopaedic Surgery, New York Presbyterian Hospital, 622 West 168th Street, PH-11, New York, NY 10032.